Annual Total Liabilities
$9.15 M
+$7.13 M+352.82%
31 December 2023
Summary:
AIM ImmunoTech annual total liabilities is currently $9.15 million, with the most recent change of +$7.13 million (+352.82%) on 31 December 2023. During the last 3 years, it has risen by +$5.86 million (+178.02%). AIM annual total liabilities is now -29.63% below its all-time high of $13.00 million, reached on 31 December 2012.AIM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$10.68 M
+$1.06 M+11.06%
30 September 2024
Summary:
AIM ImmunoTech quarterly total liabilities is currently $10.68 million, with the most recent change of +$1.06 million (+11.06%) on 30 September 2024. Over the past year, it has increased by +$5.42 million (+103.00%). AIM quarterly total liabilities is now -17.87% below its all-time high of $13.00 million, reached on 31 December 2012.AIM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +352.8% | +103.0% |
3 y3 years | +178.0% | +933.5% |
5 y5 years | +5.5% | +23.5% |
AIM Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +1015.5% | -6.0% | +1202.0% |
5 y | 5 years | at high | +1015.5% | -6.0% | +1202.0% |
alltime | all time | -29.6% | +1043.4% | -17.9% | +1234.5% |
AIM ImmunoTech Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $10.68 M(+11.1%) |
June 2024 | - | $9.61 M(-15.4%) |
Mar 2024 | - | $11.36 M(+24.2%) |
Dec 2023 | $9.15 M(+352.8%) | $9.15 M(+73.9%) |
Sept 2023 | - | $5.26 M(+51.0%) |
June 2023 | - | $3.48 M(+40.8%) |
Mar 2023 | - | $2.47 M(+22.4%) |
Dec 2022 | $2.02 M(+146.3%) | $2.02 M(-43.7%) |
Sept 2022 | - | $3.59 M(+70.6%) |
June 2022 | - | $2.10 M(+146.4%) |
Mar 2022 | - | $854.00 K(+4.1%) |
Dec 2021 | $820.00 K(-75.1%) | $820.00 K(-20.6%) |
Sept 2021 | - | $1.03 M(-13.2%) |
June 2021 | - | $1.19 M(-61.9%) |
Mar 2021 | - | $3.12 M(-5.1%) |
Dec 2020 | $3.29 M(-55.0%) | $3.29 M(+7.8%) |
Sept 2020 | - | $3.05 M(-2.5%) |
June 2020 | - | $3.13 M(-57.1%) |
Mar 2020 | - | $7.30 M(-0.2%) |
Dec 2019 | $7.31 M(-15.7%) | $7.31 M(-15.4%) |
Sept 2019 | - | $8.65 M(+19.1%) |
June 2019 | - | $7.26 M(-39.7%) |
Mar 2019 | - | $12.04 M(+38.8%) |
Dec 2018 | $8.67 M(+57.5%) | $8.67 M(-0.7%) |
Sept 2018 | - | $8.73 M(+32.5%) |
June 2018 | - | $6.59 M(+8.7%) |
Mar 2018 | - | $6.06 M(+10.1%) |
Dec 2017 | $5.50 M(+63.1%) | $5.50 M(+17.5%) |
Sept 2017 | - | $4.68 M(-18.9%) |
June 2017 | - | $5.78 M(+47.5%) |
Mar 2017 | - | $3.92 M(+16.0%) |
Dec 2016 | $3.38 M(+38.7%) | $3.38 M(-31.7%) |
Sept 2016 | - | $4.95 M(+11.7%) |
June 2016 | - | $4.43 M(+43.2%) |
Mar 2016 | - | $3.09 M(+27.1%) |
Dec 2015 | $2.43 M(-45.2%) | $2.43 M(-26.9%) |
Sept 2015 | - | $3.33 M(+7.3%) |
June 2015 | - | $3.10 M(-18.8%) |
Mar 2015 | - | $3.82 M(-13.9%) |
Dec 2014 | $4.44 M(+72.7%) | $4.44 M(+3.8%) |
Sept 2014 | - | $4.27 M(+2.2%) |
June 2014 | - | $4.18 M(+38.6%) |
Mar 2014 | - | $3.02 M(+17.4%) |
Dec 2013 | $2.57 M(-80.2%) | $2.57 M(-76.1%) |
Sept 2013 | - | $10.73 M(+7.3%) |
June 2013 | - | $10.00 M(-2.7%) |
Mar 2013 | - | $10.28 M(-20.9%) |
Dec 2012 | $13.00 M(+134.3%) | $13.00 M(+8.6%) |
Sept 2012 | - | $11.97 M(+58.0%) |
June 2012 | - | $7.58 M(+14.8%) |
Mar 2012 | - | $6.60 M(+18.9%) |
Dec 2011 | $5.55 M(-3.2%) | $5.55 M(+11.8%) |
Sept 2011 | - | $4.96 M(+26.2%) |
June 2011 | - | $3.93 M(-31.4%) |
Mar 2011 | - | $5.73 M(0.0%) |
Dec 2010 | $5.73 M | $5.73 M(+131.7%) |
Sept 2010 | - | $2.47 M(+30.2%) |
June 2010 | - | $1.90 M(-23.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $2.49 M(-60.5%) |
Dec 2009 | $6.30 M(+277.9%) | $6.30 M(+354.8%) |
Sept 2009 | - | $1.39 M(-45.4%) |
June 2009 | - | $2.54 M(+3.6%) |
Mar 2009 | - | $2.45 M(+46.8%) |
Dec 2008 | $1.67 M(-23.8%) | $1.67 M(-22.9%) |
Sept 2008 | - | $2.16 M(+11.7%) |
June 2008 | - | $1.94 M(-12.2%) |
Mar 2008 | - | $2.21 M(+0.8%) |
Dec 2007 | $2.19 M(-67.3%) | $2.19 M(-17.9%) |
Sept 2007 | - | $2.66 M(-6.8%) |
June 2007 | - | $2.86 M(-58.7%) |
Mar 2007 | - | $6.91 M(+3.5%) |
Dec 2006 | $6.68 M(+10.8%) | $6.68 M(-7.4%) |
Sept 2006 | - | $7.22 M(+6.6%) |
June 2006 | - | $6.77 M(+15.2%) |
Mar 2006 | - | $5.88 M(-2.4%) |
Dec 2005 | $6.03 M(+61.5%) | $6.03 M(+5.1%) |
Sept 2005 | - | $5.74 M(+1.1%) |
June 2005 | - | $5.67 M(+7.1%) |
Mar 2005 | - | $5.30 M(+42.0%) |
Dec 2004 | $3.73 M(-10.2%) | $3.73 M(-18.8%) |
Sept 2004 | - | $4.60 M(-6.0%) |
June 2004 | - | $4.89 M(-37.0%) |
Mar 2004 | - | $7.76 M(+86.8%) |
Dec 2003 | $4.16 M(+183.9%) | $4.16 M(-10.3%) |
Sept 2003 | - | $4.63 M(+171.8%) |
June 2003 | - | $1.70 M(-58.7%) |
Mar 2003 | - | $4.13 M(+181.8%) |
Dec 2002 | $1.46 M(+15.1%) | $1.46 M(+56.7%) |
Sept 2002 | - | $934.00 K(+14.2%) |
June 2002 | - | $818.00 K(-39.4%) |
Mar 2002 | - | $1.35 M(+6.1%) |
Dec 2001 | $1.27 M(-14.9%) | $1.27 M(+1.8%) |
Sept 2001 | - | $1.25 M(+11.3%) |
June 2001 | - | $1.12 M(-9.4%) |
Mar 2001 | - | $1.24 M(-17.1%) |
Dec 2000 | $1.50 M(+1.8%) | $1.50 M(+65.5%) |
Sept 2000 | - | $903.40 K(-27.4%) |
June 2000 | - | $1.25 M(+5.4%) |
Mar 2000 | - | $1.18 M(-19.5%) |
Dec 1999 | $1.47 M(+33.5%) | $1.47 M(-30.1%) |
Sept 1999 | - | $2.10 M(-4.5%) |
June 1999 | - | $2.20 M(+29.4%) |
Mar 1999 | - | $1.70 M(+54.5%) |
Dec 1998 | $1.10 M(+37.5%) | $1.10 M(+22.2%) |
Sept 1998 | - | $900.00 K(-10.0%) |
June 1998 | - | $1.00 M(+25.0%) |
Mar 1998 | - | $800.00 K(0.0%) |
Dec 1997 | $800.00 K(-27.3%) | $800.00 K(-42.9%) |
Sept 1997 | - | $1.40 M(+55.6%) |
June 1997 | - | $900.00 K(-10.0%) |
Mar 1997 | - | $1.00 M(-9.1%) |
Dec 1996 | $1.10 M(-86.7%) | $1.10 M(0.0%) |
Sept 1996 | - | $1.10 M(-31.3%) |
June 1996 | - | $1.60 M(+14.3%) |
Mar 1996 | - | $1.40 M(-83.1%) |
Dec 1995 | $8.30 M | $8.30 M |
FAQ
- What is AIM ImmunoTech annual total liabilities?
- What is the all time high annual total liabilities for AIM ImmunoTech?
- What is AIM ImmunoTech annual total liabilities year-on-year change?
- What is AIM ImmunoTech quarterly total liabilities?
- What is the all time high quarterly total liabilities for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly total liabilities year-on-year change?
What is AIM ImmunoTech annual total liabilities?
The current annual total liabilities of AIM is $9.15 M
What is the all time high annual total liabilities for AIM ImmunoTech?
AIM ImmunoTech all-time high annual total liabilities is $13.00 M
What is AIM ImmunoTech annual total liabilities year-on-year change?
Over the past year, AIM annual total liabilities has changed by +$7.13 M (+352.82%)
What is AIM ImmunoTech quarterly total liabilities?
The current quarterly total liabilities of AIM is $10.68 M
What is the all time high quarterly total liabilities for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly total liabilities is $13.00 M
What is AIM ImmunoTech quarterly total liabilities year-on-year change?
Over the past year, AIM quarterly total liabilities has changed by +$5.42 M (+103.00%)